Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management

    ... lenalidomide , hypomethylating agents, intensive chemotherapy , and allogeneic stem cell transplantation. The use of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... of the enzymes needed for cell growth. Drugs used in chemotherapy , such as azacitidine , work in different ways to stop ... untreated AML, if not candidates for standard induction chemotherapy or with poor risk AML (i.e. preceding MDS, myeloproliferative ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  3. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... high risk acute myeloid leukemia. Giving low doses of chemotherapy before a donor peripheral blood stem cell transplant ... to administration of 1st dose of remission induction chemotherapy ; if a bone marrow aspirate and biopsy were obtained within 28 ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  4. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy, or that have become cancer. Sometimes ... clinical trial is studying how well giving combination chemotherapy together with radiation therapy followed by cyclosporine and ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  5. Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

    ... RATIONALE: Drugs used in chemotherapy , such as fludarabine and cyclophosphamide , ... able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy. Sometimes the transplanted cells from a ...

    Clinical Trial last updated 05/02/2016 - 2:13pm.

  6. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02143830 ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  7. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02566304 ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.

  8. A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01546038 ...

    Clinical Trial last updated 04/27/2016 - 9:27am.

  9. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... transplant, patients receive very high doses of chemotherapy and/or radiation therapy, followed by an infusion of their ... bone marrow or blood stem cells . The high-dose chemotherapy drugs and radiation are given to remove the leukemia cells in the ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  10. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... is to test the safety and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent ... induction and at least one course of consolidation chemotherapy pretransplant Patients must have a Karnofsky ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.